Literature DB >> 20509023

Lithogenic activity and clinical relevance of lipids extracted from urines and stones of nephrolithiasis patients.

Chanchai Boonla1, Phantip Youngjermchan, Somkiat Pumpaisanchai, Kriang Tungsanga, Piyaratana Tosukhowong.   

Abstract

We investigated contents and classes of urinary and stone matrix lipids, and evaluated their clinical relevance in nephrolithiasis patients. Lithogenic role of major lipid classes was explored. Urine (24 h) and stone samples were collected from 47 patients with nephrolithiasis. Control urines were obtained from 29 healthy subjects. Urinary 8-hydroxy-deoxyguanosine (8-OHdG), malondialdehyde (MDA), N-acetyl-β-glucosaminidase (NAG) activity and total proteins were measured. Total lipids were extracted from centrifuged urines (10,000 rpm, 30 min) and stones by chloroform/methanol method. Major classes of lipids were identified using multi-one-dimensional thin-layer chromatography (MOD-TLC). Influence of each lipid class purified from stone matrices on stone formation was evaluated using crystallization and crystal aggregation assays. Urinary NAG activity and 8-OHdG were significantly elevated in nephrolithiasis patients. Total lipids in centrifuged urines of the patients were not significantly different from that of controls. In nephrolithiasis, urinary excretion of total lipids was linearly correlated to urinary MDA, 8-OHdG, NAG activity and total proteins. Lipid contents in stone matrices varied among stone types. Uric acid stone contained lower amount of total lipids than calcium oxalate and magnesium ammonium phosphate stones. MOD-TLC lipid chromatograms of healthy urines, nephrolithiasis urines and stone matrices were obviously different. Triacylglyceride was abundant in urines, but scarcely found in stone matrices. Stone matrices were rich in glycolipids and high-polar lipids (phospholipids/gangliosides). Partially purified glycolipids significantly induced crystal aggregation while cholesterol was a significant inducer of both crystal formation and agglomeration. In conclusion, total lipids in centrifuged urines did not differ between nephrolithiasis and healthy subjects. Our finding suggests that the significant sources of lipids in patients' urine may be large lipids-containing particles, which are removed in centrifuged urines. However, urinary lipid excretion in nephrolithiasis patients was associated with the extent of oxidative stress and renal tubular injury. Triacylglyceride was abundant in urines, but rarely incorporated into stones. Glycolipids were principal lipid constituents in stone matrices and functioned as crystal aggregator. Cholesterol purified from stone matrices bared crystal nucleating and aggregating activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20509023     DOI: 10.1007/s00240-010-0281-6

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  21 in total

1.  Membranes and their constituents as promoters of calcium oxalate crystal formation in human urine.

Authors:  S R Khan; S A Maslamani; F Atmani; P A Glenton; F J Opalko; S Thamilselvan; C Hammett-Stabler
Journal:  Calcif Tissue Int       Date:  2000-02       Impact factor: 4.333

Review 2.  Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.

Authors:  S R Khan
Journal:  Scanning Microsc       Date:  1995-06

3.  Increased urinary excretion of lipids by patients with kidney stones.

Authors:  S R Khan; P A Glenton
Journal:  Br J Urol       Date:  1996-04

4.  ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.

Authors:  Paul Jungers; Dominique Joly; Frédéric Barbey; Gabriel Choukroun; Michel Daudon
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

5.  High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography.

Authors:  T White; S Bursten; D Federighi; R A Lewis; E Nudelman
Journal:  Anal Biochem       Date:  1998-04-10       Impact factor: 3.365

6.  Lipids and membranes in the organic matrix of urinary calcific crystals and stones.

Authors:  S R Khan; F Atmani; P Glenton; Z Hou; D R Talham; M Khurshid
Journal:  Calcif Tissue Int       Date:  1996-11       Impact factor: 4.333

Review 7.  Modulators of urinary stone formation.

Authors:  Saeed R Khan; Dirk J Kok
Journal:  Front Biosci       Date:  2004-05-01

8.  Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.

Authors:  David E Fleming; Arie Van Riessen; Magali C Chauvet; Phulwinder K Grover; Brett Hunter; Wilhelm van Bronswijk; Rosemary L Ryall
Journal:  J Bone Miner Res       Date:  2003-07       Impact factor: 6.741

9.  Ultrastructural studies of crystal-organic matrix relations in renal stones.

Authors:  P T Cheng; A D Reid; K P Pritzker
Journal:  Scan Electron Microsc       Date:  1985

10.  Aggregation and dispersion characteristics of calcium oxalate monohydrate: effect of urinary species.

Authors:  Kimberly G Christmas; Laurie B Gower; Saeed R Khan; Hassan El-Shall
Journal:  J Colloid Interface Sci       Date:  2002-12-01       Impact factor: 8.128

View more
  8 in total

1.  Lipids extracted from urines and stones of nephrolithiasis patients: clinical significance?

Authors:  Viroj Wiwanitkit
Journal:  Urol Res       Date:  2010-10-16

2.  Increased oxidative DNA damage seen in renal biopsies adjacent stones in patients with nephrolithiasis.

Authors:  Wipawee Kittikowit; Uraiwan Waiwijit; Chanchai Boonla; Preecha Ruangvejvorachai; Chaowat Pimratana; Chagkrapan Predanon; Supoj Ratchanon; Piyaratana Tosukhowong
Journal:  Urolithiasis       Date:  2014-07-15       Impact factor: 3.436

3.  In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers.

Authors:  Pajaree Chariyavilaskul; Poonsin Poungpairoj; Suchada Chaisawadi; Chanchai Boonla; Thasinas Dissayabutra; Phisit Prapunwattana; Piyaratana Tosukhowong
Journal:  Urolithiasis       Date:  2015-01-15       Impact factor: 3.436

4.  Lipidomics Reveals the Therapeutic Effects of EtOAc Extract of Orthosiphon stamineus Benth. on Nephrolithiasis.

Authors:  Yufan Chao; Songyan Gao; Na Li; Hongxia Zhao; Yong Qian; Haihong Zha; Wei Chen; Xin Dong
Journal:  Front Pharmacol       Date:  2020-08-21       Impact factor: 5.810

Review 5.  A narrative review of urinary phospholipids: from biochemical aspect towards clinical application.

Authors:  Xin Li; Kenji Nakayama; Takayuki Goto; Shusuke Akamatsu; Takashi Kobayashi; Koji Shimizu; Osamu Ogawa; Takahiro Inoue
Journal:  Transl Androl Urol       Date:  2021-04

6.  Differential human urinary lipid profiles using various lipid-extraction protocols: MALDI-TOF and LIFT-TOF/TOF analyses.

Authors:  Phornpimon Tipthara; Visith Thongboonkerd
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

7.  Premature Senescence and Telomere Shortening Induced by Oxidative Stress From Oxalate, Calcium Oxalate Monohydrate, and Urine From Patients With Calcium Oxalate Nephrolithiasis.

Authors:  Kamonchanok Chuenwisad; Pimkanya More-Krong; Praween Tubsaeng; Nattida Chotechuang; Monpichar Srisa-Art; Robin James Storer; Chanchai Boonla
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

8.  HydroZitLa inhibits calcium oxalate stone formation in nephrolithic rats and promotes longevity in nematode Caenorhabditis elegans.

Authors:  Nalinthip Lordumrongkiat; Nattida Chotechuang; Mani Iyer Prasanth; Depicha Jindatip; Chakriwong Ma-On; Kamonchanok Chuenwisad; Asada Leelahavanichkul; Tewin Tencomnao; Chanchai Boonla
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.